相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD)
Maurizio Fava et al.
MOLECULAR PSYCHIATRY (2020)
Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled Study
Vanina Popova et al.
AMERICAN JOURNAL OF PSYCHIATRY (2019)
Efficacy of Esketamine Nasal Spray Plus Oral Antidepressant Treatment for Relapse Prevention in Patients With Treatment-Resistant Depression A Randomized Clinical Trial
Ella J. Daly et al.
JAMA PSYCHIATRY (2019)
Impact of midazolam vs. saline on effect size estimates in controlled trials of ketamine as a rapid-acting antidepressant
Samuel T. Wilkinson et al.
NEUROPSYCHOPHARMACOLOGY (2019)
Association of Combined Naltrexone and Ketamine With Depressive Symptoms in a Case Series of Patients With Depression and Alcohol Use Disorder
Gihyun Yoon et al.
JAMA PSYCHIATRY (2019)
Single, Repeated, and Maintenance Ketamine Infusions for Treatment-Resistant Depression: A Randomized Controlled Trial
Jennifer L. Phillips et al.
AMERICAN JOURNAL OF PSYCHIATRY (2019)
Sustained rescue of prefrontal circuit dysfunction by antidepressant-induced spine formation
R. N. Moda-Sava et al.
SCIENCE (2019)
Features of dissociation differentially predict antidepressant response to ketamine in treatment-resistant depression
Mark J. Niciu et al.
JOURNAL OF AFFECTIVE DISORDERS (2018)
Efficacy, Safety, and Durability of Repeated Ketamine Infusions for Comorbid Posttraumatic Stress Disorder and Treatment-Resistant Depression
C. Sophia Albott et al.
JOURNAL OF CLINICAL PSYCHIATRY (2018)
Attenuation of Antidepressant Effects of Ketamine by Opioid Receptor Antagonism
Nolan R. Williams et al.
AMERICAN JOURNAL OF PSYCHIATRY (2018)
Rapid and longer-term antidepressant effects of repeated-dose intravenous ketamine for patients with unipolar and bipolar depression
Wei Zheng et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2018)
The Antidepressant Effect of Repeat Dose Intravenous Ketamine Is Delayed by Concurrent Benzodiazepine Use
C. Sophia Albott et al.
JOURNAL OF CLINICAL PSYCHIATRY (2017)
Dose-Related Effects of Adjunctive Ketamine in Taiwanese Patients with Treatment-Resistant Depression
Tung-Ping Su et al.
NEUROPSYCHOPHARMACOLOGY (2017)
A Double-Blind, Randomized, Placebo-Controlled, Dose-Frequency Study of Intravenous Ketamine in Patients With Treatment-Resistant Depression
Jaskaran B. Singh et al.
AMERICAN JOURNAL OF PSYCHIATRY (2016)
Is Off-label repeat prescription of ketamine as a rapid antidepressant safe? Controversies, ethical concerns, and legal implications
Melvyn W. Zhang et al.
BMC MEDICAL ETHICS (2016)
NMDAR inhibition-independent antidepressant actions of ketamine metabolites
Panos Zanos et al.
NATURE (2016)
Placebo response rates in antidepressant trials: a systematic review of published and unpublished double-blind randomised controlled studies
Toshi A. Furukawa et al.
LANCET PSYCHIATRY (2016)
Augmentation of response and remission to serial intravenous subanesthetic ketamine in treatment resistant depression
Paulo R. Shiroma et al.
JOURNAL OF AFFECTIVE DISORDERS (2014)
Do the dissociative side effects of ketamine mediate its antidepressant effects?
David A. Luckenbaugh et al.
JOURNAL OF AFFECTIVE DISORDERS (2014)
Clinical Predictors of Ketamine Response in Treatment-Resistant Major Depression
Mark J. Niciu et al.
JOURNAL OF CLINICAL PSYCHIATRY (2014)
Efficacy of Intravenous Ketamine for Treatment of Chronic Posttraumatic Stress Disorder A Randomized Clinical Trial
Adriana Feder et al.
JAMA PSYCHIATRY (2014)
Antidepressant Efficacy of Ketamine in Treatment-Resistant Major Depression: A Two-Site Randomized Controlled Trial
James W. Murrough et al.
AMERICAN JOURNAL OF PSYCHIATRY (2013)
Rapid and Longer-Term Antidepressant Effects of Repeated Ketamine Infusions in Treatment-Resistant Major Depression
James W. Murrough et al.
BIOLOGICAL PSYCHIATRY (2013)
Serial infusions of low-dose ketamine for major depression
Keith G. Rasmussen et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2013)
Signaling pathways underlying the rapid antidepressant actions of ketamine
Ronald S. Duman et al.
NEUROPHARMACOLOGY (2012)
The Columbia-Suicide Severity Rating Scale: Initial Validity and Internal Consistency Findings From Three Multisite Studies With Adolescents and Adults
Kelly Posner et al.
AMERICAN JOURNAL OF PSYCHIATRY (2011)
Glutamate N-methyl-D-aspartate Receptor Antagonists Rapidly Reverse Behavioral and Synaptic Deficits Caused by Chronic Stress Exposure
Nanxin Li et al.
BIOLOGICAL PSYCHIATRY (2011)
To use or not to use: an update on licit and illicit ketamine use
Jih-Heng Li et al.
SUBSTANCE ABUSE AND REHABILITATION (2011)
Consequences of chronic ketamine self-administration upon neurocognitive function and psychological wellbeing: a 1-year longitudinal study
Celia J. A. Morgan et al.
ADDICTION (2010)
Does the probability of receiving placebo influence clinical trial outcome? A meta-regression of double-blind, randomized clinical trials in MDD
George I. Papakostas et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2009)
The clinical relevance of changes in the Montgomery-Asberg Depression Rating Scale using the minimum clinically important difference approach
Gerard Duru et al.
CURRENT MEDICAL RESEARCH AND OPINION (2008)
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression
Carlos A. Zarate et al.
ARCHIVES OF GENERAL PSYCHIATRY (2006)
A double-blind, placebo-controlled study of memantine in the treatment of major depression
CA Zarate et al.
AMERICAN JOURNAL OF PSYCHIATRY (2006)
The effects of practice on the cognitive test performance of neurologically normal individuals assessed at brief test-retest intervals
A Collie et al.
JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY (2003)
Psychometric properties of the credibility/expectancy questionnaire
GJ Devilly et al.
JOURNAL OF BEHAVIOR THERAPY AND EXPERIMENTAL PSYCHIATRY (2000)
分享论文
